Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...

A spokesperson for Novo Nordisk, the manufacturer of Wegovy, said: “Wegovy is indicated for weight management, including ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...

SEATTLE (Reuters) -U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with their weight-loss injections, analysts and investors say, ...

PLAINSBORO, N.J., June 26, 2025 /PRNewswire/ -- Novo Nordisk continues expansion of patient access to Wegovy ® (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers, a global ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what ...

Drugs like Wegovy and Ozempic have become increasingly popular options for millions of people who want to reach a healthier weight. But the drugs, taken as weekly injections, aren't for everybody or ...

COPENHAGEN (KVOA) - Novo Nordisk said Wednesday that late-stage trial results for its once-daily obesity pill showed “significant” weight reduction and tolerability in line with its blockbuster Wegovy ...